Analysis of the Treatment and Survival of Sinonasal Extramedullary Plasmacytoma.

Jeff GaoChristopher C TsengGregory L BarinskyChristina H FangJordon G GrubeWayne D HsuehSoly BaredesJean Anderson Eloy

Published in: American journal of rhinology & allergy (2022)

In patients with SN-EMP five-year overall survival was found to be 74.0% with decreased survival associated with a frontal sinus primary site and being aged 60 or older. Patients receiving no treatment, chemotherapy alone, or radiotherapy with chemotherapy was associated with lower survival. Receiving surgery plus radiotherapy was associated with the highest five-year overall survival.

Keyphrases

locally advanced
early stage
physical activity
squamous cell carcinoma
functional connectivity
smoking cessation